Nuclear morphometry predicts disease-free interval for clinically localized adenocarcinoma of the prostate treated with definitive radiation therapy

International Journal of Cancer

Volumn 84, Issue 6, 1999, Pages 594-597

  Hurwitz, Mark D ^a,d   DeWeese, Theodore L ^b,c   Zinreich, Eva S ^b   Epstein, Jonathan I ^c   Partin, Alan W ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CELL NUCLEUS; CELL STRUCTURE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE-FREE SURVIVAL; DNA; HUMANS; KARYOMETRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT FAILURE;

EID: 0032804605     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991222)84:6<594::AID-IJC9>3.0.CO;2-D     Document Type: Article

References (23)

1. BORLAND, R.N., PARTIN, A.W., EPSTEIN, J.I. and BRENDLER, C.B., The use of nuclear morphometry in predicting recurrence of transitional cell carcinoma. J. Urol., 149, 272-275 (1993).
2. BOYD, J., PIENTA, K.J., GETZENBERG, R.H., COFFEY, D.S. and BARRETT, J.C., Preneoplastic alterations in nuclear morphology that accompany loss of tumor suppressor phenotype. J. nat. Cancer Inst., 83, 862-866 (1991).
3. DIAMOND, D.A., BERRY, S.J., JEWITT, H.J., EGGLESTON, J.C. and COFFEY, D.S., A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness. J. Urol., 128, 729-734 (1982).
4. EPSTEIN, J.I., BERRY, S.J. and EGGLESTON, J.C., Nuclear roundness factor, a predictor of progression in untreated stage A2 prostate cancer. Cancer, 54, 1666-1671 (1994).
5. GAETA, J.F., ASIRWATHAM, J.E., MILLER, G. and MURPHY, G.P., Histologic grading of primary prostatic cancer: a new approach to an old problem. J. Urol., 123, 689-693 (1980).
6. GEARHART, J.P., WILLMANN, J.R., BECKWITH, J.B., EPSTEIN, J.I. and PARTIN, A.W., Nuclear morphometric analysis of metastasis in Wilm's tumor after multimodal therapy: comparison with primary tumor. Urology, 45, 119-123 (1995).
7. GLEASON, D.F., Mellinger, G.T. and the Veterans Administrative Cooperative Urologic Research Group, The prediction of prognosis for prostatic carcinoma by combined histologic grading and clinical staging. J. Urol., 111, 58-64 (1974).
8. LANDIS, S.H., MURRAY, P., BOLDEN, S. and WINGO, P.A., Cancer statistics. CA Cancer J. Clin., 48, 6-29 (1998).
9. MOHLER, J.L., PARTIN, A.W., EPSTEIN, J.I., BECKER, R.L., MIKEL, U.V., SESTERHENN, I.A., MOSTOFI, F.K., GLEASON, D.F., SHAREIF, Y. and COFFEY, D.S., Prediction of prognosis in untreated stage A2 prostatic carcinoma. Cancer, 69, 511-519 (1992).
10. MOHLER, J.L., PARTIN, A.W., EPSTEIN, J.I., LOHR, W.D. and COFFEY, D.S., Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sections. J. Urol., 139, 1085-1090 (1988).
11. MOHLER, J.L., PARTIN, A.W., LOHR, W.D. and COFFEY, D.S., Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. I. Testing of a digitization system. J. Urol., 139, 1080-1084 (1988).
12. MOSTOFI, F.K., Grading of prostatic carcinoma. Cancer Chemother. Rep., 59, 111-117 (1975).
13. MULDER, J.W., OFFERHAUS, J.A., DE FEYTER, E.P., FLOYD, J.J., KERN, S.E., VOGELSTEIN, B. and HAMILTON, S.R., The relationship of quantitative nuclear morphology to molecular genetic alterations in the adenoma-carcinoma sequence of the large bowel. Amer. J. Pathol., 141, 797-804 (1992).
14. MURPHY, G.P., GAETA, J.F., PICKREN, J. and WAJSMAN, Z., Current status of classification and staging of prostate cancer. Cancer, 45 (Suppl. 7), 1889 (1980).
15. PARTIN, A.W., GEARHART, J.P., LEONARD, M.P., LEVENTHAL, B.G., YOO, J.K., CROOKS, D., EPSTEIN, J.I. and BECKWITH, J.B., The use of nuclear morphometry to predict prognosis in pediatric urologic malignancies: a review. Med. Pediatr. Oncol., 21, 222-229 (1993).
16. PARTIN, A.W., STEINBERG, G.D., PITCOCK, R.V., WU, L., PIANTADOSI, S., COFFEY, D.S. and EPSTEIN, J.I., Use of nuclear morphometry, Gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer. Cancer, 70, 161-168 (1992).
17. PARTIN, A.W., WALSH, A.C., PITCOCK, R.V., MOHLER, J.L., EPSTEIN, J.I. and COFFEY, D.S., A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis. J. Urol., 142, 1254-1258 (1989).
18. PARTIN, A.W., YOO, J., CARTER, H.B., PEARSON, J.D., CHAN, D.W., EPSTEIN, J.I. and WALSH P., The use of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage in men with localized prostate cancer. J. Urol., 150, 110-114 (1993).
19. PARTIN, A.W., YOO, J.K., CROOKS, D., EPSTEIN, J.I., BECKWITH, J.B. and GEARHART, J.P., Prediction of disease-free survival after therapy in Wilm's tumor using nuclear morphometric techniques. J. Pediatr. Surg., 29, 456-460 (1994).
20. POUND, C.R., PARTIN, A.W., EPSTEIN, J.I., SIMONS, J.W. and MARSHALL, F.F., Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinoma. Urology, 42, 243-248 (1993).
21. ROACH, M., MARQUEZ, C., YOU, H.-S., NARAYAN, P., COLEMAN, L., NSEYO, U.O., NAVVAB, Z. and CARROLL, P.R., Predicting the risk of lymph node involvement using the pre-treatment prostatic specific antigen and Gleason score in men with clinically localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys., 28, 33-37 (1994).
22. SHAEFFER, J., TEGELER, J.A., KUBAN, D.A., PHILPUT, C.B. and EL-MAHDI, A.M., Nuclear roundness factor and local failure from definitive radiation therapy for prostatic carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 24, 431-434 (1992).
23. TARDIF, C.P., PARTIN, A.W., QAQISH, B., EPSTEIN, J.P. and MOHLER, J.L., Comparison of nuclear shape in aspirated and histologic specimens of prostatic carcinoma. Anal. quant. Cytol. Histol., 14, 474-482 (1992).